Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Clinical trial NCT03018288 · TERMINATED
Trial details
- NCT number
- NCT03018288
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2022-12-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.